Balance Sheet Data

BioCryst Pharmaceuticals, Inc. (BCRX)

$8.35

-0.04 (-0.48%)

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Total Cash 104.47136.23300.37507.60424.315,304.7617,606.8458,438.23193,960.27643,766.73
Total Cash (%)
Account Receivables 4.2922.158.6529.4150.60273.39907.413,011.769,996.2233,178.09
Account Receivables (%)
Inventories 1.653.901.4212.5521.6271.77238.21790.642,624.178,709.80
Inventories (%)
Accounts Payable 7.7713.9918.7127.8114.36349.331,159.453,848.3112,772.7842,393.67
Accounts Payable (%)
Capital Expenditure -0.37-0.34-0.51-2.38-1.35-13.26-44.02-146.09-484.88-1,609.35
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.